Atlas Venture is a leading biotech venture capital firm with over 30 years of experience in building breakthrough biotech startups. The firm collaborates closely with exceptional scientists and entrepreneurs to translate high-impact science into medicines for patients. Their seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.

Since 1993, Atlas Venture has launched over 70 startups, resulting in more than 25 medicines brought to market. The firm has a disciplined approach to its funds and portfolio, focusing on building biotech companies across a spectrum of disease areas, modalities, and business models. Atlas Venture's well-established LP base comprises a marquee group of long-term institutional investors.